Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5882976 | Clinical Lymphoma Myeloma and Leukemia | 2014 | 5 Pages |
Abstract
Decitabine should be considered as a treatment option for older patients with AML and poor prognostic risk factors.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Xavier G. Thomas, Christopher Arthur, Jacques Delaunay, Mark Jones, Erhan Berrak, Hagop M. Kantarjian,